Detalhe da pesquisa
1.
Modeling the Impact of a Highly Potent Plasmodium falciparum Transmission-Blocking Monoclonal Antibody in Areas of Seasonal Malaria Transmission.
J Infect Dis
; 228(2): 212-223, 2023 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37042518
2.
Whole sporozoite immunization with Plasmodium falciparum strain NF135 in a randomized trial.
BMC Med
; 21(1): 137, 2023 04 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37024868
3.
Spontaneously reported adverse events following COVID-19 basic and booster immunizations in the Netherlands.
Vaccine
; 41(29): 4319-4326, 2023 06 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37286408
4.
Mid-Liver Stage Arrest of Plasmodium falciparum Schizonts in Primary Porcine Hepatocytes.
Front Cell Infect Microbiol
; 12: 834850, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35252038
5.
Safety, tolerability, and Plasmodium falciparum transmission-reducing activity of monoclonal antibody TB31F: a single-centre, open-label, first-in-human, dose-escalation, phase 1 trial in healthy malaria-naive adults.
Lancet Infect Dis
; 22(11): 1596-1605, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35963275
6.
A double-blind, placebo-controlled phase 1/2a trial of the genetically attenuated malaria vaccine PfSPZ-GA1.
Sci Transl Med
; 12(544)2020 05 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32434847